期刊文献+

PSEN1基因p.F105L突变相关的一个早发家族性阿尔茨海默病家系特征分析 被引量:3

Presenilin 1 p. F105L mutation was associated with a Chinese pedigree with early-onset familial Alzheimer's disease
原文传递
导出
摘要 目的探讨一个早发型阿尔茨海默病家系临床特征及其PSENl基因新突变特点。方法收集2016年就诊于河南省人民医院神经内科的一个早发型家族性阿尔茨海默病(EO-FAD)家系30例成员的临床特征(病史、体格检查及影像学检查),应用高通量二代测序及Sanger测序验证PSENl基因突变位点。同时选择100名无亲缘关系健康人作为对照。结果家系中3例成员携带PSENl基因P.F105L位点突变,临床症状和影像学结果符合阿尔茨海默病诊断。结论中国人群中发现PSEN1基因P.F105L位点突变,该位点突变可能导致此家族性阿尔茨海默病家系致病。 Objective To investigate the clinical manifestations of an early-onset Alzheimer's family and the novel mutation sites of PSEN1 gene. Methods Clinical data was collected from 30 members of a family with early onset Alzheimer's disease from Neurology Department of Henan Province People's Hospital in 2016, and high-throughput sequencing and sanger sequencing were used to detect and further validate the PSEN1 gene mutation. At the same time, 100 unrelated healthy people were selected as controls. Results A total of 3 members of the family carried PSEN1 (p. F105L mutation). The clinical symptoms or imaging of the three people were consistent with the diagnosis of Alzheimer's disease. Conclusion The p. F105L mutation of the PSEN1 gene has been found in the Chinese population, which may be involved in the pathogenesis of this familial Alzheimer's disease.
作者 魏珂 秦灵芝 王晓娟 李玮 卢芬 李书剑 Wei Ke;Qin Lingzhi;Wang Xiaojuan;Li Wei;Lu Fen;Li Shujian(Department of Neurology,People's Hospital of Zhengzhou University,Zhengzhou 450003,China)
出处 《中华医学杂志》 CAS CSCD 北大核心 2018年第41期3324-3327,共4页 National Medical Journal of China
关键词 阿尔茨海默病 早老素1基因 基因 突变 Azheimer's disease PSEN1 Gene Mutation
  • 相关文献

参考文献3

二级参考文献47

  • 1高娜,石红.围绝经期症状与激素替代治疗进展[J].大连医科大学学报,2009,31(1):98-101. 被引量:19
  • 2Glodzik-Sobanska L, Pirraglia E, Brys M, et al. The effects of nor- mal aging and ApoE genotype on the levels of CSF biomarkers for Alzheimer's disease[J]. Neurobiol Aging,2009,30(5):672-681.
  • 3Lane R M,Farlow M R. Lipid homeostasis and appolipoprotein E in the development and progression of Alzheimer's disease [J]. J Lipid Res,2005,46(5):949-968.
  • 4Martins I J, Berger T, Sharman M J, et al. Cholesterol metabolism and transport in the pathogenesis of Alzheimer's disease [J]. Neu rochem, 2009,111(6) : 1275- 1308.
  • 5Kumar V B, Frank M, Banks W A, et al. Increase in presenilin 1 (PSI) levels in senescence-accelerated mice (SAMP8) may indirect- ly impair memory by affecting amyloid precursor protein (APP) processing[J]. J Exp Biol,2009,212(Pt 4) :494-498.
  • 6Albrecht S,Bourdeau M,Bennett D, et al. Activation of caspase 6 in aging and mild cognitive impairment[J]. Pathol, 2007,170 (4) : 1200- 1209.
  • 7Roses A D, Lutz M W, Amrine Madsen H, etal. ATOMM40 vari- ablelength polymorphism predicts the age of late-onset Alzheimer's disease[J]. Pharmacogenomics J, 2010,10 (5) : 375- 384.
  • 8Bekris L M,Millard S P,Galloway N M,et al. Multiple SNPs within and surrounding the appolipoprotein E gene influence eerebrospinal fluid appolipoprotein E protein levels[J]. J Alzheimer ' s Dis, 2008, 13(3) : 255-266.
  • 9Forsell C,BjOrk B F,Lilius L,et al. Genetic association to the amy- loid plaque associated protein gene COL25A1 in Alzheimer' s dis- ease[J]. Neu robiol Aging,2010,31(3):409-415.
  • 10Qiu W Q,Folstein M F. Insulin,insulin degrading enzyme and amy loid-beta peptide in Alzheimer's disease; review and hypothesis[J]. Neuro biol Aging,2006,27(2):190-198.

共引文献23

同被引文献30

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部